Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label, Randomized, Waitlist Controlled Trial of Tart Cherry and Omega-3's for Aromatase Inhibitor Musculoskeletal Symptoms

NCT06123286 is registered in ClinicalTrials.gov with Philip Chang as lead sponsor.

NCT NCT06123286
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06123286 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label, Randomized, Waitlist Controlled Trial of Tart Cherry and Omega-3's for Aromatase Inhibitor Musculoskeletal Symptoms
Lead sponsor
Philip Chang
Phase
Phase 1
Overall status
Recruiting
Start date
September 12, 2025
Completion date
October 31, 2027
Enrollment
30 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

aromatase inhibitor associated musculoskeletal symptoms (aimss), breast cancer, joint pain